Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans.

ABSTRACT:

SUBMITTER: Klebanoff MJ 

PROVIDER: S-EPMC11157442 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature